{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T22:31:25Z","timestamp":1743028285647,"version":"3.40.3"},"publisher-location":"Cham","reference-count":85,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030880705"},{"type":"electronic","value":"9783030880712"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-88071-2_5","type":"book-chapter","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T14:03:15Z","timestamp":1652882595000},"page":"115-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Cancer by Using Nanoparticles to Modulate RHO GTPase Signaling"],"prefix":"10.1007","author":[{"given":"Paulo","family":"Matos","sequence":"first","affiliation":[]},{"given":"Joana F. S.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Jordan","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nrm.2016.67","volume":"17","author":"RG Hodge","year":"2016","unstructured":"Hodge RG, Ridley AJ (2016) Regulating Rho GTPases and their regulators. Nat Rev Mol Cell Biol 17:496\u2013510","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0092-8674(95)90370-4","volume":"81","author":"CD Nobes","year":"1995","unstructured":"Nobes CD, Hall A (1995) Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53\u201362","journal-title":"Cell"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fcell.2019.00127","volume":"7","author":"S Phuyal","year":"2019","unstructured":"Phuyal S, Farhan H (2019) Multifaceted Rho GTPase signaling at the endomembranes. Front Cell Dev Biol 7:127","journal-title":"Front Cell Dev Biol"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1101\/gad.1003302","volume":"16","author":"A Schmidt","year":"2002","unstructured":"Schmidt A (2002) Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 16:1587\u20131609","journal-title":"Genes Dev"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1042\/BC20060086","volume":"99","author":"J Tcherkezian","year":"2007","unstructured":"Tcherkezian J, Lamarche-Vane N (2007) Current knowledge of the large RhoGAP family of proteins. Biol Cell 99:67\u201386","journal-title":"Biol Cell"},{"key":"5_CR6","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50471","volume":"8","author":"AE Golding","year":"2019","unstructured":"Golding AE, Visco I, Bieling P, Bement WM (2019) Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases. Elife 8:e50471","journal-title":"Elife"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3390\/cells8091037","volume":"8","author":"Cho","year":"2019","unstructured":"Cho, Kim, Baek, Kim, Lee (2019) Regulation of Rho GTPases by RhoGDIs in human cancers. Cell 8:1037","journal-title":"Cell"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01148","volume":"420","author":"S Etienne-Manneville","year":"2002","unstructured":"Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420:629\u2013635","journal-title":"Nature"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3390\/cancers12051179","volume":"12","author":"H Jung","year":"2020","unstructured":"Jung H, Yoon SR, Lim J, Cho HJ, Lee HG (2020) Dysregulation of Rho GTPases in human cancers. Cancer 12:1179","journal-title":"Cancer"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1038\/s41388-019-0963-7","volume":"38","author":"JH Svensmark","year":"2019","unstructured":"Svensmark JH, Brakebusch C (2019) Rho GTPases in cancer: friend or foe? Oncogene 38:7447\u20137456","journal-title":"Oncogene"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/21541248.2016.1232583","volume":"7","author":"RB Haga","year":"2016","unstructured":"Haga RB, Ridley AJ (2016) Rho GTPases: regulation and roles in cancer cell biology. Small GTPases 7:207\u2013221","journal-title":"Small GTPases"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/ijc.25445","volume":"128","author":"J Zhou","year":"2011","unstructured":"Zhou J, Zhu Y, Zhang G, Liu N, Sun L, Liu M et al (2011) A distinct role of RhoB in gastric cancer suppression: suppressive effect of RhoB on gastric cancer cells. Int J Cancer 128:1057\u20131068","journal-title":"Int J Cancer"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/genes9020067","volume":"9","author":"J Ju","year":"2018","unstructured":"Ju J, Gilkes D (2018) RhoB: team oncogene or team tumor suppressor? Genes 9:67","journal-title":"Genes"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1038\/sj.onc.1211027","volume":"27","author":"RM Baldwin","year":"2008","unstructured":"Baldwin RM, Parolin DAE, Lorimer IAJ (2008) Regulation of glioblastoma cell invasion by PKC\u03b9 and RhoB. Oncogene 27:3587\u20133595","journal-title":"Oncogene"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00432-005-0033-0","volume":"132","author":"LB Beder","year":"2006","unstructured":"Beder LB, Gunduz M, Ouchida M, Gunduz E, Sakai A, Fukushima K et al (2006) Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer. J Cancer Res Clin Oncol 132:19\u201327","journal-title":"J Cancer Res Clin Oncol"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/hep.25568","volume":"55","author":"F Grise","year":"2012","unstructured":"Grise F, Sena S, Bidaud-Meynard A, Baud J, Hiriart J-B, Makki K et al (2012) Rnd3\/RhoE is down-regulated in hepatocellular carcinoma and controls cellular invasion. Hepatology 55:1766\u20131775","journal-title":"Hepatology"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbrc.2008.12.044","volume":"379","author":"K Li","year":"2009","unstructured":"Li K, Lu Y, Liang J, Luo G, Ren G, Wang X et al (2009) RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax. Biochem Biophys Res Commun 379:212\u2013216","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bbrc.2011.10.065","volume":"415","author":"J Zhou","year":"2011","unstructured":"Zhou J, Li K, Gu Y, Feng B, Ren G, Zhang L et al (2011) Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia. Biochem Biophys Res Commun 415:348\u2013354","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1517\/17460441.2015.1058775","volume":"10","author":"Y Lin","year":"2015","unstructured":"Lin Y, Zheng Y (2015) Approaches of targeting rho GTPases in cancer drug discovery. Expert Opin Drug Discovery 10:991\u20131010","journal-title":"Expert Opin Drug Discovery"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1515\/BC.2000.054","volume":"381","author":"K Aktories","year":"2000","unstructured":"Aktories K, Schmidt G, Just I (2000) Rho GTPases as targets of bacterial protein toxins. Biol Chem 381:421\u2013426","journal-title":"Biol Chem"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1128\/MCB.01029-08","volume":"29","author":"A Kazi","year":"2009","unstructured":"Kazi A, Carie A, Blaskovich MA, Bucher C, Thai V, Moulder S et al (2009) Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy. MCB 29:2254\u20132263","journal-title":"MCB"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s11523-019-00661-5","volume":"14","author":"TB Karasic","year":"2019","unstructured":"Karasic TB, Chiorean EG, Sebti SM, O\u2019Dwyer PJ (2019) A phase I study of GGTI-2418 (geranylgeranyl transferase I inhibitor) in patients with advanced solid tumors. Target Oncol 14:613\u2013618","journal-title":"Target Oncol"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0959-8049(02)00166-1","volume":"38","author":"P Haluska","year":"2002","unstructured":"Haluska P, Dy GK, Adjei AA (2002) Farnesyl transferase inhibitors as anticancer agents. Eur J Cancer 38:1685\u20131700","journal-title":"Eur J Cancer"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.chembiol.2012.05.009","volume":"19","author":"X Shang","year":"2012","unstructured":"Shang X, Marchioni F, Sipes N, Evelyn CR, Jerabek-Willemsen M, Duhr S et al (2012) Rational design of small molecule inhibitors targeting RhoA subfamily rho GTPases. Chem Biol 19:699\u2013710","journal-title":"Chem Biol"},{"unstructured":"Maldonado M d M, Dharmawardhane S (2018) Targeting Rac and Cdc42 GTPases in cancer. Cancer Res. canres;0008\u20135472.CAN-18-0619v1","key":"5_CR25"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.1073\/pnas.0307512101","volume":"101","author":"Y Gao","year":"2004","unstructured":"Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y (2004) Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci 101:7618\u20137623","journal-title":"Proc Natl Acad Sci"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"35666","DOI":"10.1074\/jbc.M703571200","volume":"282","author":"A Shutes","year":"2007","unstructured":"Shutes A, Onesto C, Picard V, Leblond B, Schweighoffer F, Der CJ (2007) Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. J Biol Chem 282:35666\u201335678","journal-title":"J Biol Chem"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/jth.12861","volume":"13","author":"S D\u00fctting","year":"2015","unstructured":"D\u00fctting S, Heidenreich J, Cherpokova D, Amin E, Zhang S-C, Ahmadian MR et al (2015) Critical off-target effects of the widely used Rac1 inhibitors NSC23766 and EHT1864 in mouse platelets. J Thromb Haemost 13:827\u2013838","journal-title":"J Thromb Haemost"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"13228","DOI":"10.1074\/jbc.M111.334524","volume":"287","author":"BL Montalvo-Ortiz","year":"2012","unstructured":"Montalvo-Ortiz BL, Castillo-Pichardo L, Hern\u00e1ndez E, Humphries-Bickley T, De La Mota-Peynado A, Cubano LA et al (2012) Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase. J Biol Chem 287:13228\u201313238","journal-title":"J Biol Chem"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.tranon.2014.07.004","volume":"7","author":"L Castillo-Pichardo","year":"2014","unstructured":"Castillo-Pichardo L, Humphries-Bickley T, De La Parra C, Forestier-Roman I, Martinez-Ferrer M, Hernandez E et al (2014) The Rac inhibitor EHop-016 inhibits mammary tumor growth and metastasis in a nude mouse model. Transl Oncol 7:546\u2013555","journal-title":"Transl Oncol"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1158\/0008-5472.CAN-14-0267","volume":"74","author":"R Sakamori","year":"2014","unstructured":"Sakamori R, Yu S, Zhang X, Hoffman A, Sun J, Das S et al (2014) CDC42 inhibition suppresses progression of incipient intestinal Tumors. Cancer Res 74:5480\u20135492","journal-title":"Cancer Res"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrd2742","volume":"8","author":"KA Whitehead","year":"2009","unstructured":"Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8:129\u2013138","journal-title":"Nat Rev Drug Discov"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","volume":"8","author":"C Chakraborty","year":"2017","unstructured":"Chakraborty C, Sharma AR, Sharma G, Doss CGP, Lee S-S (2017) Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine. Mol Therap \u2013 Nucleic Acid 8:132\u2013143","journal-title":"Mol Therap \u2013 Nucleic Acid"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC (2017) Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17:20\u201337","journal-title":"Nat Rev Cancer"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd4685","volume":"14","author":"JE Zuckerman","year":"2015","unstructured":"Zuckerman JE, Davis ME (2015) Clinical experiences with systemically administered siRNA-based therapeutics in cancer. Nat Rev Drug Discov 14:843\u2013856","journal-title":"Nat Rev Drug Discov"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B","volume":"81","author":"G Fritz","year":"1999","unstructured":"Fritz G, Just I, Kaina B (1999) Rho GTPases are over-expressed in human tumors. Int J Cancer 81:682\u2013687","journal-title":"Int J Cancer"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ymthe.2004.08.029","volume":"11","author":"J-Y Pill\u00e9","year":"2005","unstructured":"Pill\u00e9 J-Y, Denoyelle C, Varet J, Bertrand J-R, Soria J, Opolon P et al (2005) Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 11:267\u2013274","journal-title":"Mol Ther"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1089\/hum.2006.17.1019","volume":"17","author":"J-Y Pill\u00e9","year":"2006","unstructured":"Pill\u00e9 J-Y, Li H, Blot E, Bertrand J-R, Pritchard L-L, Opolon P et al (2006) Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in Xenografted aggressive breast cancer. Hum Gene Ther 17:1019\u20131026","journal-title":"Hum Gene Ther"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0169-409X(00)00133-2","volume":"46","author":"CW Pouton","year":"2001","unstructured":"Pouton CW, Seymour LW (2001) Key issues in non-viral gene delivery. Adv Drug Deliv Rev 46:187\u2013203","journal-title":"Adv Drug Deliv Rev"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1021\/nn400548g","volume":"7","author":"S Huang","year":"2013","unstructured":"Huang S, Shao K, Liu Y, Kuang Y, Li J, An S et al (2013) Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis. ACS Nano 7:2860\u20132871","journal-title":"ACS Nano"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"77183","DOI":"10.18632\/oncotarget.12854","volume":"7","author":"Y Bao","year":"2016","unstructured":"Bao Y, Guo H, Lu Y, Feng W, Sun X, Tang C et al (2016) Blocking hepatic metastases of colon cancer cells using an shRNA against Rac1 delivered by activatable cell-penetrating peptide. Oncotarget 7:77183\u201377195","journal-title":"Oncotarget"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/cancers12030665","volume":"12","author":"L Kotelevets","year":"2020","unstructured":"Kotelevets L, Chastre E (2020) Rac1 signaling: from intestinal homeostasis to colorectal cancer metastasis. Cancer 12:665","journal-title":"Cancer"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-2005-916282","volume":"18","author":"KR Sheth","year":"2005","unstructured":"Sheth KR, Clary BM (2005) Management of hepatic metastases from colorectal cancer. Clin Colon Rectal Surg 18:215\u2013223","journal-title":"Clin Colon Rectal Surg"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11010-008-9955-6","volume":"322","author":"S-Y Zhao","year":"2009","unstructured":"Zhao S-Y, Sun Y, Lai Z-S, Nan Q-Z, Li K, Zhang Z-S (2009) Inhibition of migration and invasion of colorectal cancer cells via deletion of Rac1 with RNA interference. Mol Cell Biochem 322:179\u2013184","journal-title":"Mol Cell Biochem"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41467-020-15308-7","volume":"11","author":"Q Li","year":"2020","unstructured":"Li Q, Qin T, Bi Z, Hong H, Ding L, Chen J et al (2020) Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer. Nat Commun 11:1456","journal-title":"Nat Commun"},{"key":"5_CR46","first-page":"52","volume":"7","author":"N McAndrew","year":"2018","unstructured":"McAndrew N, DeMichele A (2018) Neoadjuvant chemotherapy considerations in triple-negative breast cancer. J Target Ther Cancer 7:52\u201369","journal-title":"J Target Ther Cancer"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"e40979","DOI":"10.1371\/journal.pone.0040979","volume":"7","author":"DT Rosenthal","year":"2012","unstructured":"Rosenthal DT, Zhang J, Bao L, Zhu L, Wu Z, Toy K et al (2012) RhoC impacts the metastatic potential and abundance of breast cancer stem cells. Anderson KI, editor. PLoS One 7:e40979","journal-title":"PLoS One"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1002\/cncr.25181","volume":"116","author":"M Wu","year":"2010","unstructured":"Wu M, Wu Z, Rosenthal DT, Rhee EM, Merajver SD (2010) Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers. Cancer 116:2768\u20132782","journal-title":"Cancer"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1021\/acs.molpharmaceut.5b00114","volume":"12","author":"N Kaushal","year":"2015","unstructured":"Kaushal N, Durmaz YY, Bao L, Merajver SD, ElSayed MEH (2015) \u201cSmart\u201d nanoparticles enhance the cytoplasmic delivery of anti-RhoC silencing RNA and inhibit the migration and invasion of aggressive breast. Cancer Cells Mol Pharmaceutic 12:2406\u20132417","journal-title":"Cancer Cells Mol Pharmaceutic"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jconrel.2018.07.042","volume":"289","author":"N Kaushal","year":"2018","unstructured":"Kaushal N, Tiruchinapally G, Durmaz YY, Bao L, Gilani R, Merajver SD et al (2018) Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on \u201csmart\u201d particles. J Control Release 289:79\u201393","journal-title":"J Control Release"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1432-1033.1995.607_2.x","volume":"233","author":"I Brockhausen","year":"1995","unstructured":"Brockhausen I, Yang J-M, Burchell J, Whitehouse C, Taylor-Papadimitriou J (1995) Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem 233:607\u2013617","journal-title":"Eur J Biochem"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes J, Peruzzi PP, Lawler S (2014) MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20:460\u2013469","journal-title":"Trends Mol Med"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/cam4.775","volume":"5","author":"A Shea","year":"2016","unstructured":"Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S et al (2016) MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med 5:1917\u20131946","journal-title":"Cancer Med"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2009.06.034","volume":"386","author":"J Novakova","year":"2009","unstructured":"Novakova J, Slaby O, Vyzula R, Michalek J (2009) MicroRNA involvement in glioblastoma pathogenesis. Biochem Biophys Res Commun 386:1\u20135","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7639084","volume":"2017","author":"B Banelli","year":"2017","unstructured":"Banelli B, Forlani A, Allemanni G, Morabito A, Pistillo MP, Romani M (2017) MicroRNA in glioblastoma: an overview. Int J Genomic 2017:1\u201316","journal-title":"Int J Genomic"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8013575","volume":"2017","author":"W Szopa","year":"2017","unstructured":"Szopa W, Burley TA, Kramer-Marek G, Kaspera W (2017) Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives. Biomed Res Int 2017:1\u201313","journal-title":"Biomed Res Int"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/j.febslet.2011.08.014","volume":"585","author":"M Liu","year":"2011","unstructured":"Liu M, Tang Q, Qiu M, Lang N, Li M, Zheng Y et al (2011) miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett 585:2998\u20133005","journal-title":"FEBS Lett"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/A:1013884426692","volume":"19","author":"M-A Forget","year":"2002","unstructured":"Forget M-A, Desrosiers RR, Del M, Moumdjian R, Shedid D, Berthelet F et al (2002) The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clin Exp Metastasis 19:9\u201315","journal-title":"Clin Exp Metastasis"},{"key":"5_CR59","first-page":"91","volume":"1796","author":"R Karlsson","year":"2009","unstructured":"Karlsson R, Pedersen ED, Wang Z, Brakebusch C (2009) Rho GTPase function in tumorigenesis. Biochimica et Biophysica Acta (BBA). Rev Cancer 1796:91\u201398","journal-title":"Rev Cancer"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2015.04.002","volume":"207","author":"PM Costa","year":"2015","unstructured":"Costa PM, Cardoso AL, Cust\u00f3dia C, Cunha P, Pereira de Almeida L, Pedroso de Lima MC (2015) MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: a new multimodal gene therapy approach for glioblastoma. J Control Release 207:31\u201339","journal-title":"J Control Release"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1517\/17425247.4.2.175","volume":"4","author":"AN Mamelak","year":"2007","unstructured":"Mamelak AN, Jacoby DB (2007) Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 4:175\u2013186","journal-title":"Expert Opin Drug Deliv"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.06.036","volume":"141","author":"S Liu","year":"2017","unstructured":"Liu S, Li H, Xia L, Xu P, Ding Y, Huo D et al (2017) Anti-RhoJ antibody functionalized Au@I nanoparticles as CT-guided tumor vessel-targeting radiosensitizers in patient-derived tumor xenograft model. Biomaterials 141:1\u201312","journal-title":"Biomaterials"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1182\/blood-2010-10-315275","volume":"118","author":"L Yuan","year":"2011","unstructured":"Yuan L, Sacharidou A, Stratman AN, Le Bras A, Zwiers PJ, Spokes K et al (2011) RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG. Blood 118:1145\u20131153","journal-title":"Blood"},{"key":"5_CR64","first-page":"1","volume":"2016","author":"T-T Shi","year":"2016","unstructured":"Shi T-T, Li G, Xiao H-T (2016) The role of RhoJ in endothelial cell biology and tumor pathology. Biomed Res Int 2016:1\u20139","journal-title":"Biomed Res Int"},{"doi-asserted-by":"crossref","unstructured":"Rivolta I, Panariti, Miserocchi (2012) The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? NSA 87","key":"5_CR65","DOI":"10.2147\/NSA.S25515"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/mabi.201400376","volume":"15","author":"Y Shen","year":"2015","unstructured":"Shen Y, Leng M, Yu H, Zhang Q, Luo X, Gregersen H et al (2015) Effect of amphiphilic PCL-PEG nano-micelles on HepG2 cell migration: amphiphilic PCL-PEG regulates cell migration. Macromol Biosci 15:372\u2013384","journal-title":"Macromol Biosci"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/toxsci\/kfr331","volume":"126","author":"C-H Li","year":"2012","unstructured":"Li C-H, Liao P-L, Shyu M-K, Liu C-W, Kao C-C, Huang S-H et al (2012) Zinc oxide nanoparticles\u2013induced intercellular adhesion molecule 1 expression requires Rac1\/Cdc42, mixed lineage kinase 3, and c-Jun N-terminal kinase activation in endothelial cells. Toxicol Sci 126:162\u2013172","journal-title":"Toxicol Sci"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"11767","DOI":"10.1021\/acs.jafc.8b02952","volume":"66","author":"F Hong","year":"2018","unstructured":"Hong F, Zhou Y, Ji J, Zhuang J, Sheng L, Wang L (2018) Nano-TiO2 inhibits development of the central nervous system and its mechanism in offspring mice. J Agric Food Chem 66:11767\u201311774","journal-title":"J Agric Food Chem"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"1700392","DOI":"10.1002\/adhm.201700392","volume":"6","author":"J Ga\u010danin","year":"2017","unstructured":"Ga\u010danin J, Kovtun A, Fischer S, Schwager V, Quambusch J, Kuan SL et al (2017) Spatiotemporally controlled release of rho-inhibiting C3 toxin from a protein-DNA hybrid hydrogel for targeted inhibition of osteoclast formation and activity. Adv Healthc Mater 6:1700392","journal-title":"Adv Healthc Mater"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"29651","DOI":"10.18632\/oncotarget.4865","volume":"6","author":"X He","year":"2015","unstructured":"He X, Yuan C, Yang J (2015) Regulation and functional significance of CDC42 alternative splicing in ovarian cancer. Oncotarget 6:29651\u201329663","journal-title":"Oncotarget"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1053\/j.gastro.2008.05.052","volume":"135","author":"P Matos","year":"2008","unstructured":"Matos P, Oliveira C, Velho S, Gon\u00e7alves V, da Costa LT, Moyer MP et al (2008) B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival. Gastroenterology 135:899\u2013906","journal-title":"Gastroenterology"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1038\/sj.onc.1203621","volume":"19","author":"A Schnelzer","year":"2000","unstructured":"Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H et al (2000) Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19:3013\u20133020","journal-title":"Oncogene"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1101\/gr.140988.112","volume":"22","author":"J Liu","year":"2012","unstructured":"Liu J, Lee W, Jiang Z, Chen Z, Jhunjhunwala S, Haverty PM et al (2012) Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res 22:2315\u20132327","journal-title":"Genome Res"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1530\/JME-19-0195","volume":"63","author":"M Faria","year":"2019","unstructured":"Faria M, F\u00e9lix D, Domingues R, Bugalho MJ, Matos P, Silva AL (2019) Antagonistic effects of RAC1 and tumor-related RAC1b on NIS expression in thyroid. J Mol Endocrinol 63:309\u2013320","journal-title":"J Mol Endocrinol"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"50442","DOI":"10.1074\/jbc.M308215200","volume":"278","author":"P Matos","year":"2003","unstructured":"Matos P, Collard JG, Jordan P (2003) Tumor-related alternatively spliced Rac1b is not regulated by Rho-GDP dissociation inhibitors and exhibits selective downstream signaling. J Biol Chem 278:50442\u201350448","journal-title":"J Biol Chem"},{"key":"5_CR76","first-page":"415","volume":"2018","author":"NN Singh","year":"1828","unstructured":"Singh NN, Luo D, Singh RN (1828) Pre-mRNA splicing modulation by antisense oligonucleotides. Methods Mol Biol 2018:415\u2013437","journal-title":"Methods Mol Biol"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1242\/dmm.030148","volume":"10","author":"M Bowerman","year":"2017","unstructured":"Bowerman M, Becker CG, Y\u00e1\u00f1ez-Mu\u00f1oz RJ, Ning K, Wood MJA, Gillingwater TH et al (2017) Therapeutic strategies for spinal muscular atrophy: SMN and beyond. Dis Model Mech 10:943\u2013954","journal-title":"Dis Model Mech"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/14737175.2017.1364159","volume":"17","author":"CA Chiriboga","year":"2017","unstructured":"Chiriboga CA (2017) Nusinersen for the treatment of spinal muscular atrophy. Expert Rev Neurother 17:955\u2013962","journal-title":"Expert Rev Neurother"},{"key":"5_CR79","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1089\/nat.2016.0652","volume":"27","author":"F Shabanpoor","year":"2017","unstructured":"Shabanpoor F, Hammond SM, Abendroth F, Hazell G, Wood MJA, Gait MJ (2017) Identification of a peptide for systemic brain delivery of a morpholino oligonucleotide in mouse models of spinal muscular atrophy. Nucleic Acid Therapeutic 27:130\u2013143","journal-title":"Nucleic Acid Therapeutic"},{"doi-asserted-by":"crossref","unstructured":"Hurd CA, Mott HR, Owen D (2020) Therapeutic peptides targeting the Ras superfamily. Peptide Sci:e24165","key":"5_CR80","DOI":"10.1002\/pep2.24165"},{"key":"5_CR81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbrc.2016.12.170","volume":"483","author":"K Sakamoto","year":"2017","unstructured":"Sakamoto K, Adachi Y, Komoike Y, Kamada Y, Koyama R, Fukuda Y et al (2017) Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migration. Biochem Biophys Res Commun 483:183\u2013190","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR82","doi-asserted-by":"publisher","first-page":"7787","DOI":"10.1038\/sj.onc.1203215","volume":"18","author":"MSA Nur-E-Kamal","year":"1999","unstructured":"Nur-E-Kamal MSA, Kamal JM, Qureshi MM, Maruta H (1999) The CDC42-specific inhibitor derived from ACK-1 blocks v-Ha-Ras-induced transformation. Oncogene 18:7787\u20137793","journal-title":"Oncogene"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1074\/jbc.RA119.010077","volume":"295","author":"GJN Tetley","year":"2020","unstructured":"Tetley GJN, Murphy NP, Bonetto S, Ivanova-Berndt G, Revell J, Mott HR et al (2020) The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: a bioblockade for Ras-driven signaling. J Biol Chem 295:2866\u20132884","journal-title":"J Biol Chem"},{"key":"5_CR84","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.26717\/BJSTR.2018.08.001694","volume":"8","author":"YA Haggag","year":"2018","unstructured":"Haggag YA (2018) Peptides as drug candidates: limitations and recent development perspectives. BJSTR 8:6659\u20136662. https:\/\/doi.org\/10.26717\/BJSTR.2018.08.001694","journal-title":"BJSTR"},{"key":"5_CR85","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3389\/fbioe.2020.00822","volume":"8","author":"S Attarilar","year":"2020","unstructured":"Attarilar S, Yang J, Ebrahimi M, Wang Q, Liu J, Tang Y et al (2020) The toxicity phenomenon and the related occurrence in metal and metal oxide nanoparticles: a brief review from the biomedical perspective. Front Bioeng Biotechnol 8:822","journal-title":"Front Bioeng Biotechnol"}],"container-title":["Advances in Experimental Medicine and Biology","Nanotoxicology in Safety Assessment of Nanomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-88071-2_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T07:10:59Z","timestamp":1658128259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-88071-2_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783030880705","9783030880712"],"references-count":85,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-88071-2_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"19 May 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}